Navigation Links
Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
Date:9/22/2010

SANTA CRUZ, Calif., Sept. 22 /PRNewswire/ -- This month, Bio Careers (www.biocareers.com), formerly Bio Career Center, unveils its newly enhanced website. The updated online platform includes the largest U.S. job board for postgraduates in the life sciences, and an extensive archive of articles and professional development resources.

"While life science employers have not been spared by the recession, we've seen significant job growth," said Nick Folger, founder and president. "Our newly designed site helps candidates capitalize on this growth by offering them high-quality job leads and a wealth of information to help them compete in a competitive market. We're also providing an invaluable service to recruiting offices and university career centers, many of which are stretched thin."

With a founding membership among the nation's most prestigious universities, Bio Careers is the only career service dedicated to expanding professional options for life science PhDs and MDs. The website is partnered with 32 training institutions, and leverages relationships with leading employers to give degree candidates and mid-career level alumni access to high-quality job opportunities. The site's extensive network of life sciences employers include National Institutes of Health (NIH), Food and Drug Administration (FDA), Genentech, LEK Consulting, Mayo Clinic, SAIC-Frederick, PLoS and colleges and universities across the United States.

In addition to the website's robust job search engine, Bio Careers offers industry news, professional development articles, a bookstore and access to self-assessment tests and career tools. Resources cover a variety of topics including launching a new career in science policy, entrepreneurship, biopharma business, venture capital and mid-career growth.

Bio Careers' re-launch includes a life science industries blog, multimedia and social media features and functionality and online
'/>"/>

SOURCE Bio Careers
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Calif. , July 30, 2015  EP ... /Alcon executives have recently contacted the Company about ... begin as early as Monday, August 3, 2015.  ... quoted as saying that the coming electronic contact ... of dollars over the next several years.  Novartis ...
(Date:7/30/2015)... Calif., July 30, 2015  Amgen (NASDAQ: ... second quarter of 2015. Key results include: ... second quarter of 2014 to $5,370 million, with ... Enbrel ® (etanercept), Prolia ® (denosumab), ... and XGEVA ® (denosumab). Unfavorable changes in ...
(Date:7/30/2015)... July 30, 2015  Cleveland Clinic President Wael ... address last month that industry is compelled to adopt ... gain the efficiencies—and develop the transformational innovations -- required ... comments were preceded by Doug Kohrs , past ... moderator, who stressed that industry must add "episode of ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... A Commonwealth Fund case study notes that ... aligned "to launch innovations and organize services in ways that make ... study -- along other profiles looking at medical systems that have ... high performing health care system -- has been in the works ...
... Conatus Pharmaceuticals Inc. announced today the initiation of a ... for the treatment of liver disease associated with Hepatitis C ... treatment with approved standard of care treatments is not currently ... patients who failed standard of care treatment are expected to ...
Cached Medicine Technology:Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative 2Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative 3Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis 2
(Date:7/31/2015)... ... , ... Ticket Down is a reliable source for authentic tickets for the ... The festival will end on Sunday, August 2nd. , Music fans ... This unique and unbelievably popular festival attracts the best in entertainment from around ...
(Date:7/31/2015)... ... , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest ... this new applicator in the United States as an upgrade to the CoolSmooth applicator ... original applicator required a 2 hour treatment time. The new CoolSmooth Pro reduces ...
(Date:7/31/2015)... Washington, PA (PRWEB) , ... July 31, 2015 , ... ... specialties, is excited to launch three new Board Exam Courses. , The additions ... Smartest Doc Board Exam Prep from MDLinx makes preparing for the exam easy and ...
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most ... pursuit of a visionary image that goes beyond the boundaries of fertility medicine. ... has reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and high ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3
... Risk than Adults, OAKBROOK TERRACE, Ill., April ... to children in health care,facilities are putting young ... a Joint Commission alert issued today to improve ... Alert addresses pediatric,medication errors, and urges greater attention ...
... (ES) cells could help to pacify the immune system ... National Stem Cell Network Science Meeting will hear today ... Dr Paul Fairchild from the University of Oxford will ... succumb to rejection, they have an inherent immune-privilege which, ...
... among top 10 white-collar jobs to have during ... American,Academy of Physician Assistants (AAPA) applauds Money magazine ... have in a recession",list the personal finance magazine ... Bureau of Labor Statistics, 2008 list of 30 ...
... on ,how to, than ,how to prevent, , , THURSDAY, ... that people surfing the Web for information about suicide are ... than offering help and support. , Researchers from the universities ... one at a time, into each of the four most ...
... from Packaged Facts,Pet Insurance in North America, expects North ... during the next five years,placing sales as high as ... revenues in the overall pet market due to affluent ... and wellness of their,beloved furry family members. A conservative ...
... byproduct of plaque formation wreaks havoc on heart, lungs ... News) -- New research indicates that the fatty plaques ... , "Atherosclerosis is usually associated with plaque formation in ... research professor in pathology and laboratory medicine at Weill ...
Cached Medicine News:Health News:Joint Commission Alert: Prevent Pediatric Medication Errors 2Health News:Joint Commission Alert: Prevent Pediatric Medication Errors 3Health News:Embryonic stem cells could help to overcome immune rejection problems 2Health News:Money Magazine Ranks Physician Assistant One of Best Careers to Have in a Recession 2Health News:Suicide Data on Web Mostly Not Preventive 2Health News:North America Primed for Pet Insurance Market Expansion and Expecting $1.1 Billion by 2012 2Health News:Atherosclerosis May Also Harm Vital Organs 2Health News:Atherosclerosis May Also Harm Vital Organs 3
... Low binding technology that significantly reduces the amount ... Most other filter tips are advertised as low ... not adhering to the pipet tip. However, AvantGard ... binding of valuable molecules such as DNA, proteins, ...
Inquire...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Medicine Products: